- Home
- CCCS vs AXSM Comparison
CCCS vs AXSM Comparison
Compare CCCS & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCS
- AXSM
- Stock Information
- Founded
- CCCS 1980
- AXSM 2012
- Country
- CCCS United States
- AXSM United States
- Employees
- CCCS N/A
- AXSM N/A
- Industry
- CCCS Computer Software: Prepackaged Software
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- CCCS Technology
- AXSM Health Care
- Exchange
- CCCS Nasdaq
- AXSM Nasdaq
- Market Cap
- CCCS 5.8B
- AXSM 4.8B
- IPO Year
- CCCS N/A
- AXSM 2015
- Fundamental
- Price
- CCCS $8.67
- AXSM $104.46
- Analyst Decision
- CCCS Buy
- AXSM Strong Buy
- Analyst Count
- CCCS 7
- AXSM 15
- Target Price
- CCCS $12.57
- AXSM $171.00
- AVG Volume (30 Days)
- CCCS 9.4M
- AXSM 912.2K
- Earning Date
- CCCS 05-06-2025
- AXSM 05-05-2025
- Dividend Yield
- CCCS N/A
- AXSM N/A
- EPS Growth
- CCCS N/A
- AXSM N/A
- EPS
- CCCS 0.04
- AXSM N/A
- Revenue
- CCCS $944,800,000.00
- AXSM $385,693,000.00
- Revenue This Year
- CCCS $14.42
- AXSM $63.85
- Revenue Next Year
- CCCS $9.44
- AXSM $63.93
- P/E Ratio
- CCCS $216.75
- AXSM N/A
- Revenue Growth
- CCCS 9.05
- AXSM 42.53
- 52 Week Low
- CCCS $8.14
- AXSM $64.11
- 52 Week High
- CCCS $12.88
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- CCCS 40.03
- AXSM 41.94
- Support Level
- CCCS $8.66
- AXSM $86.99
- Resistance Level
- CCCS $9.14
- AXSM $103.75
- Average True Range (ATR)
- CCCS 0.37
- AXSM 5.84
- MACD
- CCCS 0.05
- AXSM -0.01
- Stochastic Oscillator
- CCCS 53.00
- AXSM 56.74
About CCCS CCC Intelligent Solutions Holdings Inc.
CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. It operates in a single segment being Domestic segment which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in United States and China. Majority of the revenue is generated from United States.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.